Jiangsu Nhwa Pharmaceutical
Jiangsu Nhwa Pharmaceutical Co Ltd is a Chinese pharmaceutical manufacturing enterprise headquartered in Xuzhou, Jiangsu Province, China. The company specializes in the research, development, manufacturing, and commercialization of central nervous system (CNS) medications, including psychoactive drugs, anesthetics, sedatives, and neurological therapeutic formulations. Principal revenue is derived through wholesale manufacturing sales of prescription CNS pharmaceutical products to hospitals, clinics, and medical distributors across China and international markets. Jiangsu Nhwa Pharmaceutical is publicly listed on the Shenzhen Stock Exchange.
2 of the funds FundTelligence covers report a position in Jiangsu Nhwa Pharmaceutical.
- Legal name
- Jiangsu Nhwa Pharmaceutical Co Ltd
- Sector
- Health Care
- Country
- China
- Funds holding it
- 2
Funds holding Jiangsu Nhwa Pharmaceutical
- Handelsbanken Global Index Criteria — Handelsbanken · 0.01 % (full portfolio disclosed, September 2026)
- Handelsbanken Emerging Markets Index — Handelsbanken · 0.01 % (full portfolio disclosed, September 2026)